Funding Opportunities and Deadlines

Research Priority

Artificial Pancreas Therapies

Application Due
(Letter of Intent Required)

January 30

No (Type) One Left Behind: Expanding Artificial Pancreas Adoption and Access Among Targeted Populations

Details

Milestone Date Status
Letter of Intent Required Dec 05, 2018 Passed
Application Jan 30, 2019 Next
Award Notification Aug 31, 2019
Earliest Start Oct 01, 2019
Beta Cell Regeneration and Survival

Application Due
(Letter of Intent Required)

January 31

Novel Pathways and Targets for Beta Cell Regenerating Therapies in Diabetes

Details

Milestone Date Status
Letter of Intent Required Nov 20, 2018 Passed
Application Jan 31, 2019 Next
Award Notification Jul 01, 2019
Earliest Start Sep 01, 2019
Immunotherapies

Application Due
(Letter of Intent Required)

January 07

Therapeutic Development and Early Clinical Testing of T Cell Targeted Immunotherapies for the Treatment of Type 1 Diabetes

Details

Milestone Date Status
Letter of Intent Required Oct 08, 2018 Passed
Application Jan 07, 2019 Next
Award Notification Jul 31, 2019
Earliest Start Sep 01, 2019
Mission

Application Due

December 20

JDRF National Diabetes Psychology Fellowship Program

Details

Milestone Date Status
Letter of Intent N/A
Application Dec 20, 2018 Next
Award Notification Jun 01, 2019
Earliest Start Aug 01, 2019

Ongoing Opportunities

These funding sources are typically available annually or ongoing

Conference Grants

Industry Discovery & Development Partnerships

Early-Career Patient-Oriented Diabetes Research Awards (projects in COMPLICATIONS are ineligible)
Jan 31

Career Development Awards (projects in COMPLICATIONS are ineligible)
Jan 31

Advanced Postdoctoral Fellowships (projects in COMPLICATIONS are ineligible)
Jan 31

Postdoctoral Fellowships (projects in COMPLICATIONS are ineligible)
Jan 31

Project Concepts (Strategic Research Agreement)
Feb 04

RFAs Awaiting Notification

Apr

Novel Adjunctive Therapeutic Strategies to Improve Metabolic Control in Type 1 Diabetes
Apr

Identification of Areas of Artificial Pancreas Algorithm Enhancements Through Big-Data Analysis (Part 1)
Apr

Pilot Studies for Mechanisms of T1D Disease Pathogenesis
Apr

Beta Cell Replacement Innovative Grants
Apr

Beta Cell Regeneration and Survival Innovative Grants
May

Localized Immunomodulation in Beta Cell Replacement
May

Innovative Strategies To Demonstrate “Immunological Proof-of-Mechanism” And To Explore Early Outcome Measures In Immunotherapy Trials